Dao Xin

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Locally Advanced

Molecularly Imprinted

Patients Undergoing

Top Venues

OncoTargets and therapy

Thoracic cancer

Cancer medicine

Journal of inflammation research

This page only lists publications with an associated author ORCID identifier.

Publications

Ya-Lan Yang, Dao Xin, Hui-Ke Wang, Lulu Guan, Xiangrui Meng, Taiying Lu, Xiwen Bai, Feng Wang
A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma. Journal of inflammation research 16 (2023)
Dao Xin, Yan Song, Lan Mu, Bo Zhang, Ling Qi, Jing Gao, Xingyuan Wang, Jianping Xu, Tao Qu, Jing Huang
The efficacy and safety of nanoparticle albumin bound-paclitaxel-based regimen as second- or third-line treatment in patients with advanced esophageal squamous cell carcinoma. Thoracic cancer (2023)
Jia-Lin Tang, Bo Zhang, Jian-Ping Xu, Ling Qi, Dao Xin, Lin Wang, Bing-Zhi Wang, Yan-Tao Tian, Yong Li, Jing Huang
Perioperative treatment and biomarker analysis of LP002, an anti-PD-L1 antibody, plus chemotherapy in resectable gastric and gastroesophageal junction cancer. Cancer medicine (2022)
Yao Lu, Dao Xin, Feng Wang
Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer. OncoTargets and therapy 12 (2019)